White Paper

Strategies for Accelerating the Development of Modified Release Oral Forms

How do I develop an inhaled drug product?

Quotient is your answer.

Inhaled drug development

Quotient has a 30 year track record in the development and manufacturing of inhaled drug products. We have experience across a range of drug delivery platforms including dry powder inhalers (DPIs) and solutions/suspensions for inhalation. 

With integrated capabilities and vast knowledge of nasal and pulmonary delivery, we help our clients accelerate their molecules from first-in-human, through to proof-of-concept and into full development.

Integrated capabilities and expertise for nasal and pulmonary delivery

Our extensive expertise and capabilities for nasal and pulmonary delivery include:

  • Pre-formulation and API characterisation
  • Formulation and process development
  • Inhaled device evaluation and selection
  • Clinical manufacturing and supply (Phase I-III)
  • Clinical pharmacology assessments

We have a wide range of processing and analytical equipment to support the development and manufacture of inhaled drug products:

  • Spray drying
  • Micronization
  • Blending and encapsulation
  • Aerosol characterization

Related links

Learn more about inhaled drug development

Ready to get started?

Share Your Project Needs With Us

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.